P8IP
DXCM icon

Pier 88 Investment Partners’s DexCom DXCM Stock Holding History

Pier 88 Investment Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,250
Closed -$546K – 117
2025
Q2 		$546K Buy
6,250
+2,990
+92% +$234K 0.1% 84
2025
Q1 		$223K Sell
3,260
-3,140
-49% -$256K 0.04% 95
2024
Q4 		$498K Hold
6,400
– – 0.1% 76
2024
Q3 		$429K Sell
6,400
-7,230
-53% -$594K 0.09% 77
2024
Q2 		$1.55M Buy
13,630
+3,920
+40% +$496K 0.35% 43
2024
Q1 		$1.35M Buy
9,710
+1,880
+24% +$236K 0.33% 39
2023
Q4 		$972K Sell
7,830
-4,940
-39% -$505K 0.24% 53
2023
Q3 		$1.19M Sell
12,770
-5,910
-32% -$666K 0.3% 60
2023
Q2 		$2.4M Sell
18,680
-2,490
-12% -$301K 0.59% 34
2023
Q1 		$2.46M Buy
21,170
+4,800
+29% +$537K 0.6% 33
2022
Q4 		$1.85M Sell
16,370
-4,810
-23% -$528K 0.45% 35
2022
Q3 		$1.71M Buy
21,180
+13,040
+160% +$1.1M 0.41% 43
2022
Q2 		$607K Sell
8,140
-18,884
-70% -$1.72M 0.14% 79
2022
Q1 		$3.46M Buy
27,024
+7,200
+36% +$788K 1.24% 20
2021
Q4 		$2.66M Sell
19,824
-2,400
-11% -$345K 0.57% 47
2021
Q3 		$3.04M Buy
22,224
+6,880
+45% +$868K 0.91% 26
2021
Q2 		$1.64M Buy
15,344
+3,840
+33% +$369K 0.47% 59
2021
Q1 		$1.03M Hold
11,504
– – 0.35% 62
2020
Q4 		$1.06M Sell
11,504
-4,940
-30% -$441K 0.34% 55
2020
Q3 		$1.69M Buy
16,444
+36
+0.2% +$3.76K 0.51% 43
2020
Q2 		$1.66M Buy
16,408
+1,168
+8% +$104K 0.47% 56
2020
Q1 		$1.03M Buy
15,240
+6,000
+65% +$373K 0.37% 48
2019
Q4 		$505K Buy
+9,240
New +$438K 0.2% 64
2019
Q1 		– Sell
-5,120
Closed -$153K – 101
2018
Q4 		$153K Buy
+5,120
New +$162K 0.08% 82

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pier 88 Investment Partners's DXCM Position: Q3 2025 in Review

Pier 88 Investment Partners sold out of DexCom (DXCM) in Q3 2025, closing a stake of 6,250 shares — an estimated $546K sold.

Pier 88 Investment Partners first reported a position in DXCM in Q4 2018 and held it in 24 quarters. The position peaked at $3.46M in Q1 2022. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Pier 88 Investment Partners reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Pier 88 Investment Partners sold 6,250 DexCom shares in Q3 2025, an estimated $546K.
  • Pier 88 Investment Partners first reported a position in DexCom in Q4 2018 and held it in 24 quarters.
  • Pier 88 Investment Partners's DexCom position peaked at $3.46M in Q1 2022.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Pier 88 Investment Partners's 13F filing for Q3 2025, filed 31 Oct 2025.